Issue 13 march 2019 Special Report Faecal microbiota transplantation

Numéro 13 - Faecal microbiota transplantation
Download for free

This latest issue of La Revue des Microbiotes includes a report on faecal microbiota transplantation (FMT) that is sure to surprise you because it describes a treatment that flies in the face of current medical practice.

FMT has been developed through experience instead of experiments. Science does not fully understand how this treatment works, but the results are spectacular for one narrow indication—chronic colitis caused by Clostridioides difficileE. Nevertheless, throughout medical history, no treatment has ever sparked such enthusiasm. FMT could have untold benefits and the ability to heal everything from Crohn’s disease and autism to hepatic encephalopathy.

Because patients have been quicker to try the treatment than doctors, people might be trying FMT without any guidelines or even at home. In response, ANSM (the French National Agency for the Safety of Medicines and Health Products) and the Groupe Français de Transplantation Fécale*
(French Faecal Transplantation Group) decided to implement an emergency regulatory framework.

How the treatment is defined is important. France has decided it classifies as a medicine and should only be dispensed by hospital pharmacies, which are hardly used to dealing with human excrement. In the Netherlands, however, faecal matter is defined as a tissue.

The goal of this article is to provide reliable and scientifically validated information, even if it means leaving multiple questions unanswered. With the interview of Harry Sokol, a pioneer in FMT in France and an international expert in the field, you will get a behind-the-scenes look at the early development of the technique.

Happy reading and browsing!

*www.gftf.fr

Read more

Table of contents

Special Report

Interview

  • Harry Sokol

In Brief

The Microbiota Chronicle

  • Taxonomy and classification under the microscopeBruno Pot

Microbioto News

  • Colonisation of the intestinal tract by multidrug-resistant bacteria: an independent risk factor for graft-versus-host diseaseAlexis Mosca
  • Intestinal dysbiosis: a future marker for fatigue in breast cancer?Jean-Marc Bohbot

Focus

Taxonomic Reference

Contributors

EntretienProf. Harry Sokol

Saint-Antoine Hospital, Gastroenterology and Nutrition Department, APHP, F-75012 Paris; Sorbonne University, Inserm CRSA, Inra Micalis.

Close

LoginFor free access to all issues & a notification upon publication of each new issue

Forgotten password ?

Password requestHave you forgotten your password? Enter your email address and we will send you a message with the password reset procedure.

Login

Not yet registered ?

Create an account free of charge

Create an accountFor free access to all issues & a notification upon publication of each new issue

If you wish to subscribe to the paper version of La Revue des Microbiotes and have it delivered to your door, please contact our Subscription Department: contact@microbiotes.com.

  • ?
  • As a result, I accept that my email address will be forwarded to the company PILEJE (SAS – French simplified joint stock company – with a capital of €1,190,400,00 - registered at the companies register in Paris under the number 950 450 452 – 37, Quai de Grenelle, 75738 PARIS Cedex 15)

The information included in this form is intended for the company LARENA, responsible for processing, for the purposes of processing your request and managing our relationship.

In accordance with French law no. 78-17 of 6 January 1978, as amended, and European Regulation 2016/679 of 27 April 2016, you have the right to access, correct, restrict or delete data concerning you or exercise your right to opposition or right to portability. You can exercise these rights by making a request in writing, accompanied by proof of identity, to LARENA – DPO Mr Christophe Guyomar – 1 ZI du Taillis – Champtoceaux – 49270 Orée d’Anjou, France or to dpo@larenasante.com.

For more information about the management of your personal data

*These fields are required to process your request. Without this information, we will be unable to process your request .

Already registered

Login

Sample copyAccess the first issue free of charge without creating an account

Numéro 1 - Microorganisms and mankind